Learn more
Log in
0 followers
Visgenx develops therapeutics to protect against the loss of sight from retinal disorders. Its programs are based on increasing the expression of a gene known as ELOVL2 which may regulate aging in cells critical for vision.
Industries
+1
Headquarters
Stage
Employees
Links
Marty Emanuele
Merck
161 followers
Pfizer
368 followers
Atropos Health
2 followers
Amgen
150 followers
Garuda Therapeutics
Discover companies